# Special Investigation of LipaCreon on Long-term Use in Patients With Pancreatic Exocrine Insufficiency

> **NCT01427725** · — · COMPLETED · sponsor: **Mylan Inc.** · enrollment: 579 (actual)

## Conditions studied

- Exocrine Pancreatic Insufficiency
- Pancreatic Diseases
- Digestive System Diseases

## Interventions

- **DRUG:** Lipacreon

## Key facts

- **NCT ID:** NCT01427725
- **Lead sponsor:** Mylan Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2015-01
- **Final completion:** 2015-04
- **Target enrollment:** 579 (ACTUAL)
- **Last updated:** 2022-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01427725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01427725, "Special Investigation of LipaCreon on Long-term Use in Patients With Pancreatic Exocrine Insufficiency". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT01427725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*